Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Company Description
Progenics Pharmaceuticals, Inc. engages in developing medicines for oncology. It offers clinical trials of product candidates for prostate cancer, and resumed a pivotal trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. The company was founded by Paul J. Maddon on December 1,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States